Back

AdvisorShares Psychedelics ETF

Ticker: PSIL ISIN: US00768Y2972
Add to portfolio Portfolio analysis in 2min
ETF Concentrated top holdings
TER
0.99%
Fund size
$8.29M
Holdings
13
Top 10
60.2%
Issuer
AdvisorShares
$26.33 -1.75%
Price as of 2026-08-26 · NYSE ARCA

Performance by timeframe

Rolling returns
1 Month +13.79%
6 Months +51.23%
1 Year +65.28%
5 Years -21.07% p.a.-69.34%
Since inception -21.28% p.a.-69.34%
Calendar year returns
YTD +53.35%
2025 +74.54%
2024 -19.49%
2023 -25.13%
2022 -67.24%

Key stats

AUM
8.29M
Expense ratio
0.99%
Holdings
13
1Y return
65.28%
Volatility (1Y)
40.20%
52-week range
7.10 - 16.68
Section 1

Fund overview

Fund profile data from fundamentals.

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.

Category Miscellaneous Sector
Issuer AdvisorShares
Domicile USA
Section 2

Exposure breakdown

Exposure breakdown shows how the fund is allocated across assets, sectors, regions, and size buckets.

Asset allocation

Stock US
61.23%
Stock non-US
37.92%
Cash
0.86%

Sectors

Healthcare
100.00%

Regions

North America
76.98%
Europe Developed
12.63%
United Kingdom
5.59%
Australasia
4.80%

Market cap mix

Micro
76.10%
Small
12.40%
Medium
5.09%
Section 3

Top holdings

Concentrated top holdings

Top holdings show which underlying securities drive the fund most.

Mind Medicine Inc
10.77%
Alkermes Plc
6.63%
Sage Therapeutic
6.53%
ATAI Life Sciences BV
6.44%
GH Research PLC
6.08%
Intracellular Th
5.77%
Compass Pathways Plc
5.55%
Neuronetics Inc
5.20%
Neurocrine Biosciences Inc
5.09%
ENVERIC BIOSCI.INC.DL-01
2.11%
Section 4

Performance & risk

Historical return and risk indicators over fixed windows.

Returns

YTD return 13.38%
1M return 13.79%
6M return 51.23%
1Y return 65.28%
3Y return -34.33%
5Y return -69.34%
10Y return 0.00%

Risk

Volatility (1Y) 40.20%
Volatility (3Y) 54.73%
Sharpe ratio (3Y) -0.78
Beta 0.78
52-week range 7.10 - 16.68
Section 5

Portfolio characteristics

Fund concentration and composition metrics from source fields.

Overview

Holdings count 13
Top 10 weight 60.16%
Expense ratio 0.99%
Fund size 8.29M
Turnover 73.00%
Avg. market cap 212.71

Details

Instrument metadata and source update timestamps.

Symbol PSIL
Name AdvisorShares Psychedelics ETF
Asset type ETF
Exchange NYSE ARCA
Currency USD
ISIN US00768Y2972
Country USA
Code + exchange PSIL.NYSE ARCA
Last price date 2025-01-29
Fundamentals updated 2025-01-30

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.